Investigating HPV Vaccination Uptake in Adults Aged 18-35 Seeking Care at a Health Clinic in Rural Mississippi
NCT05658198 · Status: ENROLLING_BY_INVITATION · Type: OBSERVATIONAL · Enrollment: 100
Last updated 2023-11-15
Summary
A study evaluating HPV vaccine uptake among unvaccinated patients between the ages of 18 and 35 of a mobile health clinic serving the Mississippi Delta.
Conditions
- Human Papillomavirus Vaccination
Interventions
- BEHAVIORAL
-
Counseling
Patients who first decline HPV vaccination receive a 3-5 minute counseling session on HPV and the benefits of the vaccine.
Sponsors & Collaborators
- collaborator INDUSTRY
-
Plan A Health, Inc
lead OTHER
Eligibility
- Min Age
- 18 Years
- Max Age
- 35 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2023-09-01
- Primary Completion
- 2024-09-01
- Completion
- 2024-09-01
Countries
- United States
Study Locations
More Related Trials
-
PREVENT Pilot HPV - Related Cancers Trial
NCT06738355 ·Status: COMPLETED ·Phase: NA
-
Text and Talk: A Multi-level Intervention to Increase Provider HPV Vaccine Recommendation Effectiveness
NCT05006833 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
An Evaluation of Tailored Messages to Address Parental Questions About HPV Vaccination
NCT03628885 ·Status: COMPLETED ·Phase: NA
-
Immunogenicity of Gardasil-9 HPV Vaccine in People Living With HIV
NCT05266898 ·Status: RECRUITING ·Phase: PHASE4
-
Developing a Self-persuasion Intervention Promoting Adolescent HPV Vaccination: Feasibility Trial
NCT02535845 ·Status: TERMINATED ·Phase: NA
-
A Study of Safety, Tolerability and Immunogenicity of HPV-L2 Vaccine in Healthy Adult Male and Female Subjects
NCT03929172 ·Status: COMPLETED ·Phase: PHASE1
-
Usability of HPV Vaccine Reminders
NCT03987490 ·Status: COMPLETED ·Phase: NA
-
The STOP-HPV Trial 1: Communication Intervention
NCT03599557 ·Status: COMPLETED ·Phase: NA
-
Parents' HPV Stories
NCT06704308 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Electronic Messaging to Increase Human Papillomavirus Vaccine Utilization and Adherence Among College Students
NCT01568515 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Culturally Targeted Health Communication and Receptivity to the Human Papillomavirus Vaccine Among Parents in Flint, MI
NCT07301905 ·Status: RECRUITING ·Phase: NA
-
Playing Game to Learn About Children's Vaccine Project
NCT05984849 ·Status: RECRUITING ·Phase: NA
-
Impact of a School- and Primary Care-based Multicomponent Intervention on HPV Vaccination Acceptability
NCT04945655 ·Status: COMPLETED ·Phase: NA
-
Intervention for Human Papillomavirus Vaccine Acceptance in Mexican Mothers
NCT06854354 ·Status: COMPLETED ·Phase: NA
-
Study Assessing Reduced HPV Infectivity and Transmission in HPV-Positive Women Following Vaccination With 9vHPV
NCT07303751 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Follow-up Study to Evaluate the Safety and Immunogenicity of a HPV Vaccine (580299) in North America
NCT00546078 ·Status: COMPLETED ·Phase: PHASE2
-
Study of Human Papillomavirus (HPV) 16 Vaccine in the Prevention of HPV 16 Infection in 16- to 23-Year-Old Females (V501-005)
NCT00365378 ·Status: COMPLETED ·Phase: PHASE2
-
Communication Strategies to Increase HPV Vaccination Intention
NCT06784960 ·Status: COMPLETED ·Phase: NA
-
HPV Ends Here: Increasing Uptake of the HPV Vaccine
NCT06831929 ·Status: RECRUITING ·Phase: NA
-
Efficacy Against Oral Persistent Infection, Immunogenicity and Safety of the 9-valent Human Papillomavirus Vaccine (9vHPV) in Men Aged 20-45 Years (V503-049)
NCT04199689 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Video to Promote HPV Vaccination
NCT02196454 ·Status: COMPLETED ·Phase: NA
-
Developing a Self-persuasion Intervention Promoting Adolescent HPV Vaccination
NCT02537756 ·Status: COMPLETED ·Phase: NA
-
Broad Spectrum HPV Vaccine Tolerability, Immunogenicity, and Efficacy Study (V502-003)
NCT00365443 ·Status: WITHDRAWN ·Phase: PHASE2
-
The STOP-HPV Trial 3: Prompts Intervention
NCT03599583 ·Status: UNKNOWN ·Phase: NA
-
The STOP-HPV Trial 5: Single Arm Evaluation of the Bundle
NCT03609320 ·Status: UNKNOWN ·Phase: NA